PHYSICIAN-LED
Private Investment
POWERING TOMORROW'S HEALTH
Healthcare investment from angel entrepreneur backing to management and M&A. Our fund focuses on healthcare innovation with strategic expertise.
WHO WE ARE
Healthcare Investment
Redefined
FUND 41 is a physician-led private investment fund that brings unparalleled medical expertise and strategic insight to healthcare investing. Our unique approach combines clinical knowledge with business acumen to identify and nurture the most promising healthcare innovations.
From angel entrepreneur backing to management buyouts and mergers & acquisitions, we provide comprehensive support across the entire investment lifecycle. Our team's deep understanding of healthcare operations, regulatory landscapes, and market dynamics positions us to create exceptional value.
We partner with visionary entrepreneurs and established healthcare companies to accelerate growth, optimize operations, and drive meaningful impact in patient care and healthcare delivery.
FUND OVERVIEW
Strategic Healthcare Investment
Investment Focus
- Healthcare technology and digital health platforms
- Medical device innovation and biotechnology
- Healthcare services and care delivery models
- Pharmaceutical development and therapeutics
- Healthcare infrastructure and support services
Angel to M&A
Comprehensive support from early-stage angel backing through growth capital to management buyouts and strategic acquisitions.
Portfolio Approach
Diversified healthcare investments with active management and strategic guidance from experienced physician-investors.
Key Differentiators
Physician Leadership
Clinical expertise driving investment decisions
Proven Track Record
Multiple successful exits and NASDAQ listings
Strategic Network
Deep healthcare industry connections and partnerships
OUR APPROACH
Investment Strategy & Process
Deal Sourcing
Leveraging our extensive healthcare network to identify high-potential investment opportunities across the healthcare ecosystem.
Due Diligence
Comprehensive clinical, operational, and financial analysis combining medical expertise with rigorous business evaluation.
Value Creation
Active partnership with portfolio companies providing strategic guidance, operational support, and industry connections.
Exit Strategy
Strategic exit planning through IPOs, strategic acquisitions, or secondary sales to maximize returns for all stakeholders.
LEADERSHIP
Adam Nadelson, MD
Founder & Managing Partner
Dr. Adam Nadelson is a visionary physician-entrepreneur with a proven track record of building and scaling successful healthcare ventures. As the CEO and Founder of The IV Doc, he revolutionized mobile healthcare delivery, creating a nationwide network that has served hundreds of thousands of patients.
He is the Co-Founder of Pasithea Therapeutics (NASDAQ: KTTA), a publicly-traded biopharmaceutical company focused on developing innovative treatments for psychiatric and neurological disorders. His leadership has guided the company through successful IPO and regulatory milestones.
With multiple successful exits and a reputation as a strategic investor, Dr. Nadelson has been recognized as one of America's Top Healthcare Entrepreneurs. His unique combination of clinical expertise, business acumen, and investment experience positions FUND 41 at the forefront of healthcare innovation.
Dr. Nadelson's investment philosophy centers on identifying transformative healthcare solutions that improve patient outcomes while generating exceptional returns. His extensive network and deep industry knowledge enable FUND 41 to access premier deal flow and provide unparalleled value to portfolio companies.
GET IN TOUCH
Partner With
Healthcare Innovators
Explore investment opportunities and strategic partnerships with FUND 41. Let's discuss how we can power tomorrow's health together.
Location
San Juan, PR